Robert obtained his MD and doctoral degree in immunology from LMU Munich, Germany. After his postdoc at UNC Chapel Hill, he was recruited to Columbia University in 2003. His goal is to use innovative approaches to better understand mechanisms of liver disease and develop novel treatments for fatty liver, fibrosis and cancer.
Aveline obtained her PhD in Medical Science in Rennes, France where she studied hepatocyte death. Since she joined the Schwabe lab in 2017, she is investigating the role of liver fibrosis and hepatic stellate cells in the development of hepatocellular carcinoma .
Ajay completed his joint-PhD from IIT Bombay (India) and Monash University (Australia), and postdoc with Dr. Andrea Califano at Columbia University. He develops and uses computational tools to study transcriptional regulation. His current main focus is to identify aberrant regulators in liver fibrosis and cancer.
Yoshi is a physician-scientist with clinical activities in Gastroenterology and Hepatology and research experience in mechanisms of chronic liver disease. He obtained a PhD from Osaka University, and joined in the Schwabe lab in 2019. His long-term goal is to to bridge basic research with clinically relevant questions and models in the areas of fatty liver, fibrosis and HCC.
Qiuyan received her BS in Nutritional Sciences from Cornell University and joined the Schwabe lab in 2021 for her PhD thesis. She is interested in finding therapeutic vulnerabilities for intrahepatic cholangiocarcinoma. Outside lab, she is an amateur writer in science fictions.
Deqi graudated Medical School in China in 1983, and worked as physician majoring in infectious diseases. After working in the Kandel lab for over a decade, he joined the. Schwabe Lab, in 2016. Deqi supervises all transgenic mice for projects related to hepatic stellate cell biology and liver carcinogenesis.
Atsushi is a surgeon-scientist in Gastrointestinal (GI) and Hepato-Pancreato-Biliary (HPB) cancer. He obtained a PhD from Osaka City University (Japan) and joined in the Schwabe lab in 2022. His research interest is to elucidate desmoplastic cancer progression and his goal is to establish the novel therapies for hepato-pancreato-biliary cancer.
Oscar graduated from The City College of New York with a Bachelor of Science in Biology, accompanied with pre-medical studies. Oscar wishes to employ laboratory science - and the excitement of experimental success - in a clinical setting or on the bench. In addition, he is an avid runner with over 6 completed marathons, a regular volunteer, and enjoys baking. Run Oscar run!
Back to Barcelona, where I am starting my own group supported by grants from the ERC and La Caixa.
Back in Munich, where I seek to establish my own group focusing on liver cancer immunology